Possibility to Obtain Anti-Athrax Human Immunoglobulin for Intravenous Injection

Possibility to Obtain Anti-Athrax Human Immunoglobulin for Intravenous Injection

For the first time specific Ig was obtained from blood plasma of donors immunized by combined anthrax vaccine. This Ig conforms to quality standards for intravenous immunoglobulins and includes antibodies to Bacillus anthracis protective antigen in titer 1:1600 - 1:3200. Therapeutic and prophylactic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Problemy osobo opasnyh infekcij 2008-04 (2(96)), p.39-42
Hauptverfasser: Dolmatov, V. Yu, Drobkova, A. V., Lyutov, A. G., Mal’tseva, O. V., Shevtsov, A. N., Borovskoy, D. V., Yelagin, G. D., Karpova, M. V., Vershinina, O. A., Blinova, E. A., Sharygin, S. L.
Format: Artikel
Sprache:eng ; rus
Schlagworte:
anthrax
human immunoglobulin
prophylaxis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:For the first time specific Ig was obtained from blood plasma of donors immunized by combined anthrax vaccine. This Ig conforms to quality standards for intravenous immunoglobulins and includes antibodies to Bacillus anthracis protective antigen in titer 1:1600 - 1:3200. Therapeutic and prophylactic efficacy of experimental-production series of preparation was demonstrated in experiments with animals.
ISSN:0370-1069
2658-719X
DOI:10.21055/0370-1069-2008-2(96)-39-42